May 17, 2012, 11:45 amKBC Securities expects substantial price reductions by Hungarian drugs producer Egis as a consequence of the so-called blind bidding process. After a meeting between Egis’s management and analysts...
May 16, 2012, 3:14 pmHungary’s listed drugs maker Egis maintains its guidance for a 8-10% revenue decline on its domestic market in 2012, but it has lowered its estimate for sales growth both for Russia and the Commonwealth...
May 16, 2012, 10:38 am(Adds details, charts) The first-quarter results of Hungarian drugs maker Egis were overall better than what the market expected. The company’s operating and net profits overshot the respective...
May 14, 2012, 12:15 pmAnalysts polled by Portfolio.hu project that net profit of Hungarian drugs maker Egis grew by 20% year-on-year in the first quarter of 2012, while the consensus estimate for the company’s EBIT (earnings...
May 9, 2012, 1:35 pmHungarian drug producers Egis and Richter are expected to report smaller profits for the first quarter of 2012 than their respective Q1 2011 numbers, the consensus estimates of analysts showed in a Portfolio.hu...
March 30, 2012, 2:18 pmHungarian drugs marker Egis has announced on Friday that the influence of U.S.-based Tradewinds Global Investors in the company dropped to below 10%. Tradewinds is a U.S.-based investment fund management...
March 27, 2012, 5:50 pmHungary’s Egis Pharmaceuticals announced that, in line with AstraZeneca’s request, the court added Egis as a defendant in the patent litigation between plaintiff AstraZeneca and defendant Watson...
March 19, 2012, 3:49 pmHungary’s drug prices to be in effect from 1 April have become final last week with a ‘blind bidding’ by producers. Both Richter and Egis had to carry out massive price reductions at...
February 9, 2012, 11:41 amManagement of Hungarian pharmaceutical producer Egis lowered their estimate for 2012 domestic and eastern European sales. The company reported higher-than-expected EBIT for Q4 2012 and a small overshoot...
February 9, 2012, 9:11 am(Adds details, charts) Egis, Hungary’s second-largest drugs producer, has reported higher-than-expected profit numbers for the fourth quarter of 2011 on Wednesday after market close. The company’s...
January 26, 2012, 9:10 amShareholders of Hungarian drugs producer Egis approved every proposal of the Board of Directors at the company’s annual general meeting on Wednesday. This means shareholders will be entitled to...
November 10, 2011, 9:08 amHungarian drugs producer Egis published weaker-than-expected profit numbers for the third quarter of 2011. While the company’s revenues and gross profit came in largely in line with the consensus...
November 7, 2011, 12:01 pmHungary’s two key drug makers, Richter and Egis, will publish their preliminary earnings reports for the third quarter of 2011 next week. The consensus estimates in Portfolio.hu’s poll showed...
November 3, 2011, 9:19 amHungarian drugs producer Egis has announced that the local business tax will be allocated from operating expense into corporate tax line. Egis has announced that, in line with the modification of auditing...
October 11, 2011, 8:25 amRaiffeisen has lowered its target price for Hungary’s Egis to HUF 19,655 from HUF 21,485 previously, while it changed its recommendation to ‘Buy’ from ‘Hold’, saying the drugs...
September 28, 2011, 5:05 pmTradewinds Global Investors has by share purchases over the past few days exceeded the 10% shareholding limit in Hungarian drugs producer Egis, above which reporting is obligatory by law. The U.S.-based...
